Site # 0122 — Rapid City, South Dakota

Site # 0122 is a clinical research site located in Rapid City, South Dakota, United States 57701.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site # 0122 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Paroxysmal Supraventricular Tachycardia.

Sponsors: Milestone Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site # 0122?

Site # 0122 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site # 0122 conducted?

Site # 0122 has 1 clinical trials on record, with 1 currently active. Their work covers Paroxysmal Supraventricular Tachycardia.

Is Site # 0122 accredited by Crixeo Health?

Site # 0122 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site # 0122?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.